| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Lidia Sabater, Albert Giralt, Anna Boronat, Karolina Hankiewicz, Yolanda Blanco, Sara Llufriu, Jordi Alberch, Francesc Graus, Albert Sai. Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in vitro study. Journal of neuroimmunology. vol 215. issue 1-2. 2009-11-09. PMID:19695715. |
nmo-igg is a disease-specific autoantibody for neuromyelitis optica (nmo) that binds selectively to aquaporin-4 (aq4), an astrocytic water channel. |
2009-11-09 |
2023-08-12 |
Not clear |
| Grazia Paola Nicchia, Mauro Mastrototaro, Andrea Rossi, Francesco Pisani, Carla Tortorella, Maddalena Ruggieri, Anna Lia, Maria Trojano, Antonio Frigeri, Maria Svelt. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies. Glia. vol 57. issue 13. 2009-10-30. PMID:19229993. |
neuromyelitis optica (nmo) is an inflammatory autoimmune demyelinating disease of the central nervous system (cns) which in autoantibodies produced by patients with nmo (nmo-igg) recognize a glial water channel protein, aquaporin-4 (aqp4) expressed as two major isoforms, m1- and m23-aqp4, in which the plasma membrane form orthogonal arrays of particles (oaps). |
2009-10-30 |
2023-08-12 |
Not clear |
| J H Min, H J Kim, B J Kim, K W Lee, I N Sunwoo, S M Kim, B J Kim, S H Kim, M S Park, P Waters, A Vincent, J J Sung, K H Le. Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica. Multiple sclerosis (Houndmills, Basingstoke, England). vol 15. issue 9. 2009-10-30. PMID:19625331. |
however, brain abnormalities of ss remain to be elucidated for the association with neuromyelitis optica (nmo). |
2009-10-30 |
2023-08-12 |
Not clear |
| S M Kim, P Waters, A Vincent, S Y Kim, H J Kim, Y H Hong, K S Park, J H Min, J J Sung, K W Le. Sjogren's syndrome myelopathy: spinal cord involvement in Sjogren's syndrome might be a manifestation of neuromyelitis optica. Multiple sclerosis (Houndmills, Basingstoke, England). vol 15. issue 9. 2009-10-30. PMID:19692434. |
to evaluate clinical characteristics, aquaporin (aqp)-4 antibody results, and probability of developing symptoms of neuromyelitis optica (nmo) in patients with sjögren's syndrome myelopathy (ssm). |
2009-10-30 |
2023-08-12 |
Not clear |
| Romain Cayrol, Philippe Saikali, Thierry Vincen. Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica. Annals of the New York Academy of Sciences. vol 1173. 2009-10-29. PMID:19758189. |
nmo-igg autoantibody is now considered a useful serum biomarker of neuromyelitis optica (nmo). |
2009-10-29 |
2023-08-12 |
Not clear |
| Shoichi Ito, Masahiro Mori, Takahiro Makino, Sei Hayakawa, Satoshi Kuwabar. "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Annals of neurology. vol 66. issue 3. 2009-10-29. PMID:19798642. |
neuromyelitis optica (nmo) is presumably mediated by an autoantibody against aquaporin-4 densely expressed at the blood-brain barrier. |
2009-10-29 |
2023-08-12 |
Not clear |
| Shumei Bai, Shilian Liu, Xuxiao Guo, Zhaoyu Qin, Banqin Wang, Xiaohong Li, Yanjiang Qin, Yi-Hsin Li. Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients. Molecular vision. vol 15. 2009-10-27. PMID:19710940. |
to better understand the pathophysiological mechanisms underlying neuromyelitis optica (nmo), we developed a proteomics platform for biomarker discovery in the cerebrospinal fluid (csf) of patients with nmo. |
2009-10-27 |
2023-08-12 |
Not clear |
| Xiaoli Guo, Chikako Harada, Kazuhiko Namekata, Kenji Kikushima, Yoshinori Mitamura, Hiroshi Yoshida, Yoh Matsumoto, Takayuki Harad. Effect of geranylgeranylacetone on optic neuritis in experimental autoimmune encephalomyelitis. Neuroscience letters. vol 462. issue 3. 2009-10-26. PMID:19616065. |
since it can cause irreversible visual loss, especially in the optic-spinal form of ms or neuromyelitis optica (nmo), the present study was conducted to assess the effects of geranylgeranylacetone (gga) on optic neuritis in the experimental autoimmune encephalomyelitis (eae) mouse model of ms. myelin oligodendrocyte glycoprotein-induced eae mice received oral administration of gga at 500 mg/kg or vehicle once daily for 22 days. |
2009-10-26 |
2023-08-12 |
mouse |
| Anu Jacob, Marcelo Matiello, Brian G Weinshenker, Dean M Wingerchuk, Claudia Lucchinetti, Elizabeth Shuster, Jonathan Carter, B Mark Keegan, Orhun H Kantarci, Sean J Pittoc. Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Archives of neurology. vol 66. issue 9. 2009-10-23. PMID:19752302. |
neuromyelitis optica (nmo) is the first inflammatory autoimmune demyelinating disease of the central nervous system for which a specific antigenic target has been identified; the marker autoantibody nmo-igg specifically recognizes the astrocytic water channel aquaporin 4. |
2009-10-23 |
2023-08-12 |
Not clear |
| Sajjad Nasir, Douglas A Kerr, Julius Birnbau. Nineteen episodes of recurrent myelitis in a woman with neuromyelitis optica and systemic lupus erythematosus. Archives of neurology. vol 66. issue 9. 2009-10-23. PMID:19752308. |
to describe the case of a patient with systemic lupus erythematosus (sle) and neuromyelitis optica (nmo) who experienced 19 recurrent attacks of myelitis. |
2009-10-23 |
2023-08-12 |
Not clear |
| Shannon R Hinson, Andrew McKeon, James P Fryer, Metha Apiwattanakul, Vanda A Lennon, Sean J Pittoc. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. Archives of neurology. vol 66. issue 9. 2009-10-23. PMID:19752309. |
recent reports support a pathogenic role in neuromyelitis optica (nmo) for the aquaporin-4 (aqp4)-specific autoantibody (nmo-igg). |
2009-10-23 |
2023-08-12 |
Not clear |
| Denis Bernardi Bichuetti, René Leandro Magalhães Rivero, Enedina Maria Lobato de Oliveira, Daniel May Oliveira, Nilton Amorin de Souza, Roberto Gomes Nogueira, Nitamar Abdala, Alberto Gabba. White matter spectroscopy in neuromyelitis optica: a case control study. Journal of neurology. vol 255. issue 12. 2009-10-12. PMID:19159058. |
brain lesions not typical of ms have been described in neuromyelitis optica (nmo), and correspond to brain aquaporin-4 channel sites, but the evaluation of naa/cr ratio in nawm of patients with nmo and its association to the presence of brain lesions and clinical disability have not been described. |
2009-10-12 |
2023-08-12 |
Not clear |
| Shimon Amemiya, Makoto Hamamoto, Tomoaki Kumagai, Masayuki Ueda, Yasuo Katayama, Keiko Tanak. Neuromyelitis optica preceded by brain demyelinating episode. Journal of neuroimaging : official journal of the American Society of Neuroimaging. vol 19. issue 3. 2009-10-09. PMID:18681925. |
neuromyelitis optica (nmo) is considered a distinct disease from multiple sclerosis (ms) because of its pathogenesis. |
2009-10-09 |
2023-08-12 |
Not clear |
| Masami Tanaka, Keiko Tanaka, Mika Komor. Interferon-beta(1b) treatment in neuromyelitis optica. European neurology. vol 62. issue 3. 2009-10-09. PMID:19590215. |
the effects of interferon-beta(1b) (ifn-beta(1b)) administration in multiple sclerosis (ms) patients have been confirmed, however, those in neuromyelitis optica (nmo) patients have not been shown. |
2009-10-09 |
2023-08-12 |
Not clear |
| H L Pellkofer, C Suessmair, A Schulze, R Hohlfeld, T Kuempfe. Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab. Multiple sclerosis (Houndmills, Basingstoke, England). vol 15. issue 8. 2009-10-08. PMID:19667025. |
in neuromyelitis optica (nmo), the monoclonal b-cell antibody rituximab is a therapeutic option. |
2009-10-08 |
2023-08-12 |
Not clear |
| Daniela Baumann Cornelio, Regina Pedrini Braga, Marcos Wengrover Rosa, Antônio Celso Ayu. Devic's neuromyelitis optica and pregnancy: distinction from multiple sclerosis is essential. Archives of gynecology and obstetrics. vol 280. issue 3. 2009-10-06. PMID:19151993. |
devic's neuromyelitis optica (nmo) is a severe neurological disease characterized by optic neuritis and transverse myelitis, which is commonly misdiagnosed as multiple sclerosis (ms). |
2009-10-06 |
2023-08-12 |
Not clear |
| Daniel Blackburn, John Robin Highley, Steve Wharton, Charles Romanowski, John Bowen, Basil Sharrac. Antibody-negative neuromyelitis optica with heavy B-cell infiltration. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. vol 117. issue 10. 2009-10-06. PMID:19775346. |
neuromyelitis optica (nmo) is often associated with a specific antibody, suggesting a distinct pathogenesis. |
2009-10-06 |
2023-08-12 |
Not clear |
| Arne Wart. Prevention of orthogonal array of particles formation as a treatment approach for neuromyelitis optica. Medical hypotheses. vol 73. issue 3. 2009-09-22. PMID:19398170. |
neuromyelitis optica (nmo) is an uncommon, life-threatening demyelinating disease that produces transverse myelitis and optic neuritis. |
2009-09-22 |
2023-08-12 |
Not clear |
| S Ravaglia, S Bastianello, D Franciotta, M Ceroni, A Pichiecchio, E Tavazzi, A Moglia, E Marchion. NMO-IgG-negative relapsing myelitis. Spinal cord. vol 47. issue 7. 2009-09-21. PMID:19104509. |
idiopathic transverse myelitis (i-tm) is typically monophasic, while relapsing forms are usually referred to spinal cord-restricted neuromyelitis optica (nmo), atypical multiple sclerosis (ms), or myelitis during the course of infections and connectivitis. |
2009-09-21 |
2023-08-12 |
Not clear |
| Shabana Karim, Vikas Majithi. Devic's syndrome as initial presentation of systemic lupus erythematosus. The American journal of the medical sciences. vol 338. issue 3. 2009-09-18. PMID:19745613. |
devic's syndrome or neuromyelitis optica (nmo) is an inflammatory demyelinating disease of the central nervous system associated with optic neuritis, myelitis involving 3 or more contiguous spinal cord segments, and seropositivity for nmo-igg antibody. |
2009-09-18 |
2023-08-12 |
Not clear |